Clinuvel Pharmaceuticals Limited today announced that the US Food and Drug Administration (FDA) has allowed the company to proceed under its current Investigational New Drug to conduct a pilot Phase II clinical trial of its drug afamelanotide (known as SCENESSE®) in patients diagnosed with nonsegmental vitiligo.
Today there are over 25 facilities around the world searching for a cure for vitiligo. Here is where they can be found and what they are doing for us.
Through some very lucky clicking I came across a Dissertation written by Deborah Herbstman, entitled, “The Role of Genetics in Vitiligo”.
It’s not often that I receive an email that I want to share with others, but this came to my box today from one of my best friends and I think you might enjoy it, too! Handbook for 2011
There have been many comments asking about UVB treatment for vitiligo, so I will tell you about my experience with it. One summer, years ago, I did a personal experiment to see if the sun could repigment my vitiligo. Each day I sat in the sun for 15-30 min and every day brought new dark […]
It’s day 9 of the new year and over the past week I have been bombarded with that age old question, “what’s your new year’s resolution?”, and I have been inundated, online, with unsolicited advice on how to fulfill some of the more common resolutions. So once again, I got out my notebook (somehow this […]
Want easy access to ideas our readers have tried to cure vitiligo? Looking for a simple way to get all of the information about vitiligo from our site?
The meeting “Medicine & Me: Vitiligo”, organised jointly with the Vitiligo Society, will bring together patients, their families, caregivers, advocates, patient support groups, clinicians and researchers to discuss Vitiligo. This meeting will focus on initial experiences at diagnosis, psychological aspects of the disease with especial reference to issues of ethnicity, and issues around patient pathways […]